Edwards Lifesciences: Zovighian proposes $4.76M sale

The notice assigns a $4,759,559 aggregate market value to the shares and says the options may be sold over various dates.

Available on EDGAR 11/09/2026 - 04:22 PM EST Accepted by SEC EDGAR 11/09/2026 - 04:21 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Edwards Lifesciences Corp (EW) lists a notice by Bernard J. Zovighian, an officer and director, covering a proposed sale of 46,200 common shares with an aggregate market value of $4,759,559. The shares were acquired on November 9, 2026 through an employee stock option exercise, with broker payment for a cashless exercise. The notice gives November 9, 2026 as the approximate sale date and says the options may be sold over various dates. It lists July 28, 2026 as the plan adoption or instruction date for reliance on Rule 10b5-1.

Key Figures

Shares covered by proposed sale notice: 46,200 common shares Aggregate market value: $4,759,559 Shares outstanding: 575,000,000 shares +2 more

5 metrics

Shares covered by proposed sale notice 46,200 common shares Proposed sale

Aggregate market value $4,759,559 Shares covered by proposed sale notice

Shares outstanding 575,000,000 shares Share count listed in the notice

Approximate sale date November 9, 2026 The remarks say the options may be sold over various dates

Rule 10b5-1 plan adoption or instruction date July 28, 2026 Date listed for reliance on Rule 10b5-1

Key Terms

Rule 10b5-1, Employee Stock Option Exercise, Cashless Exercise

3 terms

Rule 10b5-1 regulatory

"Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

Employee Stock Option Exercise technical

"Employee Stock Option Exercise - See Remarks"

Cashless Exercise technical

"Broker Payment for Cashless Exercise"

A cashless exercise is a way for an option holder to convert stock options into actual shares without paying the purchase price in cash; instead they immediately give up a portion of the newly issued shares to cover the cost and any withholding taxes. Investors care because this process increases the number of shares available and can slightly dilute existing holdings, while also signaling how insiders or employees are realizing compensation without needing cash — similar to paying for a purchase by handing over part of what you just bought.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many EW shares does Bernard J. Zovighian plan to sell?

The notice covers a proposed sale of 46,200 common shares, with an aggregate market value of $4,759,559.

When does the EW sale take place, and is it under a Rule 10b5-1 plan?

The notice gives November 9, 2026 as the approximate sale date and says the options may be sold over various dates. It lists July 28, 2026 as the plan adoption or instruction date for reliance on Rule 10b5-1.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001665141
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Edwards Lifesciences Corp
SEC File Number	001-15525
Address of Issuer	ONE EDWARDS WAY IRVINE CALIFORNIA 92614
Phone	9492502500
Name of Person for Whose Account the Securities are To Be Sold	Zovighian Bernard J
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	46200	4759559.00	575000000	11/09/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/09/2026	Employee Stock Option Exercise - See Remarks	EDWARDS LIFESCIENCES CORPORATION			46200	11/09/2026	Broker Payment for Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The options on this filing may be sold over various dates.
Date of Notice	11/09/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	07/28/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Bernard J Zovighian
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)